Access Speech & Language Pathology, Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1956 Harvard Dr, Eugene, OR 97405 Phone: 406-210-5954 |
Tyler William Wood Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1500 W 12th Ave, Eugene, OR 97402 Phone: 541-346-2578 |
Lisa A Wagner, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1500 W 12th Ave, Eugene, OR 97402 Phone: 541-346-2578 |
Emily M Garrett, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2285 Elysium Ave, Eugene, OR 97401 Phone: 503-442-1950 |
Ms. Deborah Muriel Rock, M.S.P.A., CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 1500 W 12th Ave, Eugene, OR 97402 Phone: 541-485-8521 Fax: 541-485-6159 |
Eugene Speech Therapy Llc Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 385 W 2nd Ave, Eugene, OR 97401 Phone: 541-600-2028 |
Sarah A Knudsen, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1158 High St Ste 102, Eugene, OR 97401 Phone: 541-342-1980 Fax: 541-342-6207 |
Crystal Adame Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1445 Willamette St Ste 3, Eugene, OR 97401 Phone: 971-346-0355 |
Linda Hesketh, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 N Monroe St, Eugene, OR 97402 Phone: 541-790-7638 |
Kelly Makana Smith- Ladore, SLPA Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 425 Alexander Loop, Eugene, OR 97401 Phone: 541-345-6199 |
Rebecca Ansen, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 N Monroe St, Eugene, OR 97402 Phone: 541-790-7638 |
Amanda Williams, M.S. CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 38 W 30th Ave, Unit A, Eugene, OR 97405 Phone: 720-312-2765 |
Mr. John Michael Mclean, M.SC., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1500 W 12th Ave, Eugene, OR 97402 Phone: 541-485-8521 |
Rowan Bupp, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1724 City View St, Eugene, OR 97402 Phone: 541-232-8805 Fax: 877-313-0633 |
Katharine Ankeny, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 200 N Monroe St, Eugene, OR 97402 Phone: 541-790-7638 |
Hannah Oh, M.S., CCC-SLP Speech-Language Pathologist Medicare: Medicare Enrolled Practice Location: 901 E 18th Ave, Eugene, OR 97403 Phone: 310-948-9225 |
Amber Plaunty, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 470 River Rd, Eugene, OR 97404 Phone: 541-556-0721 |
Community Rehabilitation Services Of Oregon Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1501 Pearl St, Suite B, Eugene, OR 97401 Phone: 541-342-1980 Fax: 541-342-6207 |
Mark Detweiler, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1500 W 12th Ave, Eugene, OR 97402 Phone: 541-284-4880 Fax: 541-485-6159 |
Mrs. Emily Catherine Adler Mosqueda, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 4245 Fox Hollow Rd, Eugene, OR 97405 Phone: 541-517-0053 |
News Archive
A widely under-recognized form of arthritis, ankylosing spondylitis (AS) is a chronic, progressive disease targeting the spine.
An Australian research team from the Peter MacCallum Cancer Centre, the University of Melbourne and the University of Queensland has identified a new risk factor for developing breast cancer. This has been published online in the journal Cancer Prevention Research.
Although neurofibromatosis (NF) is not commonly discussed, it affects more than 2 million people worldwide.
Arum Han, professor in the Department of Electrical and Computer Engineering at Texas A&M University, and his collaborators have designed an experimental system that shows exposure of SARS-CoV-2 to a very high temperature, even if applied for less than a second, can be sufficient to neutralize the virus so that it can no longer infect another human host.
​BiondVax Pharmaceuticals Ltd., a clinical stage biopharmaceutical company focused on developing and commercializing immunomodulation therapies for infectious diseases, today announced the closing of an additional and partial exercise of the over-allotment option granted to the underwriters.
› Verified 3 days ago